Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries
Background The novel coronavirus (COVID-19) has an affinity for almost every organ system, including the skin. This review article will compile and compare dermatology guidelines related to the dermatologic care of patients during the COVID-19 pandemic. Objective To review and compare the available...
Main Authors: | Mary Beth Gadarowski, Esther A. Balogh, Arjun M. Bashyam, Steven R. Feldman |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-04-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2020.1808154 |
Similar Items
-
Reliability of Past Medical History in a Single Hospital Participating in Get With The Guidelines‐Stroke Registry
by: Christopher G. Favilla, et al.
Published: (2022-07-01) -
Heart failure guidelines implementation: Lifting barriers using registries and networks
by: Kalliopi Keramida, et al.
Published: (2020-07-01) -
Data from the Russian Severe Asthma Registry (RSAR)
by: Andrey S. Belevskiy, et al.
Published: (2022-08-01) -
Etiology of Bronchiectasis in the World: Data from the Published National and International Registries
by: Jose Daniel Gómez-Olivas, et al.
Published: (2023-09-01) -
Primary results of the brazilian registry of atherothrombotic disease (NEAT)
by: Pedro G. M. de Barros e Silva, et al.
Published: (2024-02-01)